Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Stock
Equities
688621
CNE100005139
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.69 CNY | +1.51% | -2.88% | -17.29% |
Sales 2024 * | 1.27B 176M | Sales 2025 * | 1.66B 229M | Capitalization | 6.46B 892M |
---|---|---|---|---|---|
Net income 2024 * | 304M 41.97M | Net income 2025 * | 422M 58.26M | EV / Sales 2024 * | 5.08 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.89 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
13.5
x | Employees | 1,126 |
Yield 2024 * |
1.46% | Yield 2025 * |
2.08% | Free-Float | 51.4% |
1 day | +1.51% | ||
1 week | -2.88% | ||
Current month | -7.27% | ||
1 month | -7.27% | ||
3 months | -9.24% | ||
6 months | -12.71% | ||
Current year | -17.29% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Liu
CEO | Chief Executive Officer | 42 | 09-02-28 |
Ling Yang Zhao
DFI | Director of Finance/CFO | 36 | 20-03-20 |
Ming Juan Wang
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qian Li
CHM | Chairman | 43 | 09-03-08 |
Qiao Chen
BRD | Director/Board Member | 44 | 20-03-20 |
Zhuang Kun He
BRD | Director/Board Member | 52 | 20-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 57.69 | +1.51% | 2,421,281 |
24-04-26 | 56.83 | -1.81% | 3,093,878 |
24-04-25 | 57.88 | +1.87% | 955,661 |
24-04-24 | 56.82 | -0.46% | 676,600 |
24-04-23 | 57.08 | -3.91% | 1,206,173 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.29% | 892M | |
+1.77% | 42.86B | |
+46.34% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- 688621 Stock